Key findings from the 48-week study include: Significant Weight Loss: Subjects receiving pemvidutide achieved mean weight losses of 10.3%, 11.2%, and 15.6% at the 1.2 mg, 1.8 mg, and 2.4 mg doses, respectively, compared to 2.2% for placebo
Disease activity markers, including polyarthritis, dactylitis, and systemic inflammation, were linked to higher CV event risk, and atherosclerotic plaque burden correlated with PsA severity
From drugstore staples to dermatologist-brand products, the options are overwhelming
The user profile would also shift and manufacturers would need to think carefully about the varying nutritional needs of those taking them for that purpose
A SingleCare discount card can help lower your prescription costs if price is a concern
The Promoting Effect of Pentadecapeptide BPC 157 on Tendon Healing Involves Tendon Outgrowth, Cell Survival, and Cell Migration